Cat.#: BBM-3C-082
Description | 3D PVA-HA Hydrogel Kit contains the necessary reagents for creating hydrogels containing hyaluronic acid, which are SG-PVA and HyLink, a thiol-functionalized hyaluronic acid crosslinker. The formation of a gel through the stable bonding of thiol groups on HyLink with thiol-reactive groups on SG-PVA, when the two reagents are combined at physiological pH (pH 7.2). |
Unit | 1 kit |
Components | BBM-3C-082-A, SG-PVA, 170 µl BBM-3C-082-B, HyLink, 2 × 200 µl BBM-3C-082-C, 10x CB (pH 7.2), 200 µl |
Storage | -80 ℃ |
Shipping | Dry ice |
Applications | 3D cell cultures |
Citation Guidance | If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. |
Cat.# | Name | Description | Price |
---|---|---|---|
BBM-3C-074 | 3D F-Dextran-CD Hydrogel Kit |
3D Dextran-CD Hydrogel Kit contains the necessary reagents for creating hydrogels that gel fast and are compatible with living cells, which are maleimide functionalized dextran (Mal-Dextran), and CD-Link, a cross-linking agent. The formation of a gel through the stable bonding of thiol groups on CD-Link with maleimide groups on the Mal-Dextran, when the two reagents are combined.
|
inquiry |
BBM-3C-120 | 3D Hydrogel Kit (Native) |
3D Hydrogel Kit (Native), a natural, animal-free, ready-to-use hydrogel, creates a 3D cell culture environment that mimics the extracellular matrix (ECM) to support cell growth and differentiation.
|
inquiry |
BBM-3C-091 | 3D 10x CB Buffer (pH 7.2) |
3D 10x CB-Buffer (pH 7.2), a buffer solution, provides a cell environment at pH 7.2 for the formation of slow-gelling 3D hydrogels.
|
inquiry |
BBM-3C-113 | 3D Hydrogel Kits (ECM) |
3D Hydrogel Kits (ECM) is used to artificially create a three-dimensional (3D) cell culture environment. The kit consists of an extracellular matrix with a microporous structure from human sources.
|
inquiry |
BBM-3C-116 | 3D Cell Culture Hydrogel Matrix Kit (RGD) |
3D Cell Culture Hydrogel Matrix Kit (RGD) is a high-concentration, adjustable, xeno-free (animal source-free) hydrogel system. This system was modified with the cell adhesion peptide RGD to promote cell attachment and cell-matrix interactions during 3D cell culture.
|
inquiry |
BBM-3C-078 | 3D S-Dextran-CD Hydrogel Kit |
3D Dextran-CD Hydrogel Kit contains the necessary reagents for creating hydrogels that gel slowly and are compatible with living cells, which are SG-Dextran and CD-Link, a cross-linking agent. The formation of a gel through the stable bonding of thiol groups on CD-Link with thiol-reactive groups on SG-Dextran, when the two reagents are combined at physiological pH (pH 7.2).
|
inquiry |
BBM-3C-109 | ECM Gel from Engelbreth-Holm-Swarm Murine Sarcoma |
ECM Gel From Engelbreth-Holm-Swarm Murine Sarcoma is prepared from Engelbreth-Holm-Swarm sarcoma in mice for 3D cell culture.
|
inquiry |
BBM-3C-080 | 3D S-Life PVA-CD Hydrogel SG Kit |
3D PVA-CD Hydrogel Kit contains the necessary reagents for creating hydrogels that gel slowly and are compatible with living cells, which are polymeric SG-PVA and CD-Link, a cross-linking agent. The formation of a gel through the stable bonding of thiol groups on CD-Link with thiol-reactive groups on SG-PVA, when the two reagents are combined at physiological pH (pH 7.2).
|
inquiry |
BBM-3C-103 | 3D Cell Culture Hydrogel (100% Peptide) |
3D Cell Culture Hydrogel (100% Peptide) from Ace Therapeutics is a peptide synthetic hydrogel without any animal-derived or bioactive ingredients that can be used as an ideal three-dimensional cell culture scaffold.
|
inquiry |
BBM-3C-112 | 3D RGD-CD Hydrogel Kits |
3D Hydrogel Kits (Pre-Configured), a pre-configured 3D hydrogel system, consists of RGD (arginyl glycyl aspartate) degradable polymer and CD cell degradable cross-linking agent. When RGD and CD cross-linkers are mixed, they cross-link into a gel.
|
inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.